Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance snapshot: Health care burden attributable to osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Image of Cover 4. Air Force security forces trainees climb a hill during a 3-mile ruck march to commemorate National Police Week at Joint Base San Antonio, May 13, 2019. Photo By: Sarayuth Pinthong, Air Force

Osteoarthritis (OA) and spondylosis (OA of the spine) can result in pain and functional impairment and account for significant morbidity burdens among U.S. civilian and military populations.1–3 Management of cases of OA requires substantial health care resources and incurs considerable costs.4 A recent MSMR analysis described the incidence of OA and spondylosis diagnoses among active component service members of the U.S. Armed Forces during 2016–2020.5 Crude annual incidence rates of both conditions decreased markedly from 2016 through 2020 with declines evident in all of the demographic and military subgroups examined.5

This snapshot summarizes the total numbers of inpatient and outpatient encounters with an OA or spondylosis diagnosis in the first diagnostic position and the total numbers of unique individuals affected by these conditions during the same 5-year surveillance period. Totals included both incident and prevalent cases. Among active component service members during 2016–2020, a total of 71,338 unique individuals were affected by OA (Table). These individuals contributed a total of 211,607 OA-related medical encounters, representing an average of 3 medical encounters per affected individual. The vast majority (99.9%) of the total OA-related medical encounters were in outpatient settings. Service members affected by OA who had 1 or more OA-related hospitalizations (n=276) were associated with a total of 1,409 hospital bed days.

Between 2016 and 2020, a total of 86,485 unique individuals were affected by spondylosis (Table). These individuals had a total of 335,693 spondylosis-related medical encounters, representing 4 medical encounters per affected individual. Similar to OA, the vast majority (99.8%) of the total spondylosis-related medical encounters were in outpatient settings. Spondylosis-related hospitalizations (n=790) accounted for a total of 2,482 hospital bed days.

References

1. Abramoff B, Caldera FE. Osteoarthritis: Pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104(2):293–311.

2. Vina ER, Kwoh CK. Epidemiology of osteoarthritis: Literature update. Curr Opin Rheumatol. 2018;30(2):160-167.

3. Armed Forces Health Surveillance Division. Absolute and relative morbidity burdens attributable to various illnesses and injuries, active component, U.S. Armed Forces, 2020. MSMR. 2021;28(5):2–9.

4. Centers for Disease Control and Prevention. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation United States, 2010–2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):869–873.

5. Williams VF, Ying S, Stahlman S. Update: Osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020. MSMR. 2021;28(12):2–13.

TABLE. Counts of medical encounters(a) with first-listed osteoarthritis or spondylosis diagnoses and unique individuals affected(b), by encounter type, active component, U.S. Armed Forces, 2016–2020

You also may be interested in...

Topic
Apr 8, 2024

Medical Surveillance Monthly Report

The Medical Surveillance Monthly Report, a peer-reviewed journal launched in 1995, is the Armed Forces Health Surveillance Division's flagship publication. The MSMR provides monthly evidence-based estimates of the incidence, distribution, impact, and trends of health-related conditions among service members.

Report
Mar 1, 2024

MSMR Vol. 31 No. 3 - March 2024

.PDF | 1.34 MB

The March 2024 MSMR features a comparison of 2018 estimates from the HRBS and the PHA on tobacco and nicotine use among the U.S. military active component; followed by a report on coverage of HIV PrEP among active duty service members in 2023; supplemented by a Surveillance Snapshot of HIV PrEP prescriptions in 2023 in the active component; then a ...

Article
Mar 1, 2024

Coverage of HIV Pre-Exposure Prophylaxis Within the Active Duty U.S. Military, 2023

This study provides the first estimate of HIV pre-exposure prophylaxis coverage in the U.S. military, defined as the proportion of the persons taking HIV PrEP out of the estimated number of persons who had indications for it, that is also comparable to U.S. civilian estimates. The population with indications for HIV PrEP was obtained from the ...

Article
Mar 1, 2024

Mid-Season Influenza Vaccine Effectiveness Estimates Among DOD Populations: A Composite of Data Presented at VRBPAC—the Vaccines and Related Biological Products Advisory Committee—2024 Meeting on Influenza Vaccine Strain Selection for the 2024-2025 Influenza Season

This is an introduction to a composite of three Surveillance Snapshots of Department of Defense data on mid-season influenza vaccine effectiveness that were presented at the 2024 VRBPAC meeting.

Article
Mar 1, 2024

Tobacco and Nicotine Use Among Active Component U.S. Military Service Members: A Comparison of 2018 Estimates from the Health Related Behaviors Survey and the Periodic Health Assessment

This study compared estimates of the prevalence of and risk factors for tobacco and nicotine use obtained from the 2018 Health Related Behaviors Survey and Periodic Health Assessment survey. The HRBS and the PHA are important Department of Defense sources of data on health behavior collected from U.S. military service members.

Skip subpage navigation
Refine your search
Last Updated: May 10, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery